CANN    another short if it breaks 2.20, will be careful for squeezes

SCYX      up on analyst upgrade price target of $16

AUPH    this is gaped up a dollar before the market opened today, up on drug PR and now an increase remission rate for treatment announcement AND positive results from study

ABEO     nice breakout but didn’t completely hold its gains, this was a dud today and not enough volume as of now has a nice catalyst with approval of second clinical trials for a syndrome

LPCN    

MCUR   up on a merger agreement

IPCI        tentative FDA approval announced 10^th

MOBL    up from announcement of their Q3 outlook with positive numbers, had a steady uptrend all day, will see how it plays out tomorrow

AREX     nice bounce from Fridays close and attempted to break the res but failed to hold till close, no news lately.

EBIO      held support today off of its fall, expecting a following fade tomorrow